CAITLYN GREENE: Open Payments
NPI 1902596380 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,019 in 97 payments from 20 companies in 2025. Trend: 2023 $38 · 2024 $1,347 · 2025 $2,019
Food & beverage: $1,974Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 17 | $333 |
| Novo Nordisk Inc | 14 | $308 |
| Amgen Inc. | 15 | $280 |
| Amneal Pharmaceuticals LLC | 11 | $204 |
| Tandem Diabetes Care, Inc. | 5 | $111 |
| Mannkind Corporation | 4 | $84 |
| Xeris Pharmaceuticals, Inc. | 4 | $82 |
| SANOFI-AVENTIS U.S. LLC | 3 | $78 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $73 |
| ABBVIE INC. | 4 | $58 |
Products named: MOUNJARO, UNITHROID, TEPEZZA, Ozempic, t:slim X2 Insulin Pump with Control-IQ, EVENITY, AFREZZA, GVOKE HYPOPEN.
Industry payments across GA — which companies pay providers there.
